Latest Announcements

Granules India Limited has announced its financial results for the quarter ended September 30, 2026, with revenue from operations at INR 15,600 Mn, up 20% YoY, EBITDA at INR 3,376 Mn, up 21% YoY, and PAT at INR 1,818 Mn, up 39% YoY.

Gandhar Oil Refinery (India) Limited has informed the Exchange about the transcript of the earnings call for Q2 & H1 FY27, where the company's management discussed their financial results, including revenue and profit growth, and addressed ongoing challenges in the market.

Aeroflex Industries Ltd reported its Q2 FY27 earnings, with revenue crossing the INR200 crore milestone for the first time. The company's diversified business model, strong demand for core products, and increasing traction in the liquid cooling vertical contributed to the growth. The merger of Hyd-Air Engineering, a wholly-owned subsidiary, is expected to streamline operations, optimize resource allocation, and reduce administrative costs.

Aeroflex Industries Limited has announced its Q2 FY27 financial results, with revenue crossing the INR200 crore milestone for the first time. The company reported strong growth in its metal flexible hose business and assemblies and other value-added products business. The liquid cooling vertical contributed 24% to the revenue in H1 FY27, making a significant milestone in the company's evolution.

Bajaj Auto Ltd announced Q2 FY27 results, with record performance in volumes, revenue, EBITDA, PAT, and free cash flow, despite challenging operating environment.

Nelcast Ltd has announced its unaudited standalone and consolidated financial results for the quarter and half-year ended 30th September 2026. The company's revenue from operations for the quarter stood at ₹40,505.39 lakhs, with a total income of ₹40,955.91 lakhs. The profit before tax for the quarter was ₹2,197.83 lakhs, and the profit for the period was ₹1,620.30 lakhs. The company's paid-up equity share capital remains at ₹17,400.02 lakhs, with a face value of ₹2.00 per share.

Strides Pharma Science Limited has informed the Exchange about Transcript of Earnings Call to discuss the unaudited financial results for the quarter and half year ended September 30, 2026. The company has achieved its FY28 growth aspiration, with Ex-US revenue contributing more than the US revenue. The company has reported a strong second quarter with revenue reaching ₹14,297 million, growing 17% year-on-year and 13% quarter-on-quarter, led by Ex-US markets.

Apcotex Industries Limited has informed the Exchange about the transcript of the earnings conference call held on 29th October 2026, for the 2nd Quarter and First Half of Financial Year 2027. The company's financial and operational highlights include a 48% year-on-year growth in operating revenues, a 44% year-on-year growth in operating EBITDA, and a 156% year-on-year growth in profit after tax.

Strides Pharma Science Ltd reported its highest quarterly revenue of ₹14,297 million, a 17% year-on-year growth, led by its Ex-US markets. The company's Ex-US revenue now contributes 49% of its total revenues, up from 43% in Q2 last year. Gross margin grew 13% year-on-year to ₹8,003 million, and EBITDA grew 8% year-on-year to ₹2,509 million, crossing the ₹2,500 million mark in a single quarter for the first time.

Container Corporation of India Ltd has announced the outcome of its board meeting held on 02.11.2026, where it approved the un-audited standalone and consolidated financial results for the quarter and period ended on 30th September, 2026. The board also declared a 2nd Interim Dividend for FY 2026-27 of 38% i.e. Rs.1.90 per equity share of face value of Rs.5/- each amounting to Rs.144.71 crores.

Sanghvi Movers Limited announced unaudited financial results for Q2 & H1 FY27, with revenue from operations at Rs. 277 Cr and 32% YoY growth, and EBITDA at Rs. 106 Cr and 20% YoY growth.

Sanghvi Movers Ltd announced its unaudited financial results for Q2 and H1 FY27, with revenue from operations at Rs. 277 Cr and Rs. 657 Cr respectively, and a 32% and 36% YoY growth in revenue. The company also secured an order book of Rs. 1,582 Cr as on 23 Oct'26, driven by strong contributions from SML and SFRPL.

Apcotex Industries Ltd announced its Q2 & H1 FY27 Earnings Conference Call transcript, highlighting strong business performance with 48% year-on-year growth in operating revenues, 44% growth in operating EBITDA, and 38% growth in profit after tax. The company's EBITDA margins expanded by 599 basis points to 17.12%, and PAT margins improved to 11.11% from 6.25% earlier.

JSW Cement Limited has informed the Exchange about the transcript of the results conference call for the quarter and half year ended 30th September 2026. The company's management discussed the challenging external environment, but remains constructive on the demand outlook for the balance of the year. They highlighted the company's momentum in the North region, EBITDA breakeven at Nagaur, and the additional 1 million ton per annum grinding capacity.

Refex Industries Ltd reported solid execution in its established business and encouraging early progress in its new business segment, ready-mix concrete. The company's revenue and PAT showed a healthy year-on-year progress, with revenue up by 36% and PAT up by 13% in Q2FY27 and PAT up by 56% in H1 FY27. The company is focused on accelerating executions, mobilizing new secured orders, and converting opportunities into profitable growth.

MOIL Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a net profit of ₹ 6,177.76 crore and ₹ 14,939.37 crore respectively. The company has also declared an interim dividend of ₹ 2.20 per equity share.

Sakar Healthcare Limited has informed the Exchange about Transcript of Con Call. The company has shared the transcript of the discussion on the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended September 30, 2026, at the analyst meet held on October 27, 2026. The transcript is attached and also available on the website of the Company.

PNB Housing Finance Limited has informed the Exchange about the transcript of Earnings Conference Call held on October 28, 2026, for Q2 and H1 FY26-27. The company's credit rating has been upgraded to AAA by CRISIL with a stable outlook. Key highlights for the quarter include a 60% YoY growth in overall disbursements, a 54% YoY growth in retail disbursements, and an improvement in GNPA to 0.91%.

Beta Drugs Limited has informed the Exchange regarding 'Machine Readable / legible copy of Financial Results for the period ended 30-Sep-2026'. The company's growth was led by a 21% rise in CMO business, and the company expects to close FY27 Branded Oncology at INR 150 Crs. in line with the guidance.

Refex Industries Limited's Q2 FY27 earnings call discussed solid execution in established business and encouraging early progress in new business, with revenue up 36% and PAT up 13% YoY, despite weather-related challenges.